MarkTechPost reported that Google DeepMind released AlphaGenome 2 on November 11, 2026. The publication described the system as a conditional DNA sequence model that predicts regulatory activity and genetic variant effects for specific cell types.
According to MarkTechPost, the model is available through the AlphaGenome API for non-commercial research, giving researchers access to the reported cell-type-specific prediction capabilities under that stated condition.
The release, its capabilities and the API availability are based on MarkTechPost’s reporting. No official Google DeepMind announcement or independent corroborating source was supplied with the evidence for this report.